Headline: Moving the bar(rier) forward: the benefits of de-risking cytokine release syndrome

By SAMANTHA MCCLENAHAN Every breakthrough in cancer treatment brings hope, but it also comes with a staggering price, raising a critical question: how do we balance groundbreaking advances with the financial reality that could limit access for many patients?  Developing new cancer medications involves extensive research, clinical trials, and regulatory approvals; a lengthy process that…

Read More

Building Patient Trust in Digital Health Software

We need apps that have been tested with real users to ensure they are intuitive and easy to use. The apps also need to be designed to be inclusive of different needs including patients with disabilities, different levels of tech literacy, and diverse needs.  The post Building Patient Trust in Digital Health Software appeared first…

Read More

State Medicaid Officials Project Flat Enrollment Post Unwinding but Increased Spending and Budget Pressures, as States Prepare for Impact of Federal Medicaid Policy Changes

As states completed the “unwinding” of pandemic-era continuous coverage, Medicaid enrollment fell 7.6% in FY 2025 and is expected to be largely flat in FY 2026, according to KFF’s 25th annual Medicaid Budget Survey. At the same time, total Medicaid spending grew by 8.6% in FY 2025 and is expected to grow by 7.

Read More

Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL

That is the title of my recent publication with co-authors Andrea Chung, Sachin Vadgama, Kristen Hurley, Miguel-Angel Perales, Leonard Clarkson Alsfeld, Sanjana Muthukrishnan and Anik R Patel, Gunjan L Shah, Richard T Maziarz. The abstract is below. CAR T-cell therapy has shown curative potential for patients with diffuse large B-cell lymphoma (DLBCL) and other malignancies,…

Read More